Results 1 to 10 of about 6,663,297 (230)

IL-33 Drives Endothelial-to-Mesenchymal Transition in Pulmonary Hypertension. [PDF]

Hypertension
Jankauskas SS, Kansakar U, Varzideh F, Santulli G.   +3 more
europepmc   +1 more source

Occurrence of drug resistance, associated risk factors, and expression of cytokine IL-33 in human TB patients. [PDF]

Ann Med Surg (Lond)
Aslam S, Ali S, Gul ST, Arshad MI.
europepmc   +1 more source

The IL-33/ST2 pathway to modulate the inflammatory microenvironment: A new therapeutic target in chronic obstructive pulmonary disease. [PDF]

Biochem Biophys Rep
Xie X, Yang L, Chen J, Wu Y, Zhong J, Shen H, Zheng G.   +6 more
europepmc   +1 more source

IL-33 blockade in asthma: a story of hype, hope and hindsight. [PDF]

ERJ Open Res
Georas SN, Bourdin A.
europepmc   +1 more source

Exosomes from IL-33-Stimulated Macrophages Regulate Epithelial Barrier Function to Ameliorate TNBS-Induced Colitis in Mice. [PDF]

Cells
Liu S, Cao Y, Chen L, Nie Q, Liu W, Zhao Y, Yuan B, Liu T, Liu Y, Yin H.   +9 more
europepmc   +1 more source

Targeting ANGPTL3 and IL-33/ST2 Ameliorates Diabetic Kidney Disease by Reducing Lipotoxicity, Alleviating Inflammation and Inhibiting Fibrosis. [PDF]

Adv Sci (Weinh)
Li Z, Cao Z, Zhou R, Cheng X, Hu X, Xu S, Dou Z, Du L, Ju D.   +8 more
europepmc   +1 more source

IL-33 Modulates Cytotoxic NK Cell Subsets in Severe Eosinophilic Asthma. [PDF]

Life (Basel)
Bergantini L, Paggi I, Pianigiani T, Bargagli E, Cameli P.   +4 more
europepmc   +1 more source

Targeting mir130b-IL-33-PD-L1 axis effectively inhibits esophageal squamous carcinoma progression. [PDF]

Transl Oncol
Yue Y, Xian W, Yuan Y, Wang X, Wu P, Sha X, Yue X.   +6 more
europepmc   +1 more source

IL-33: targeting a muscle-to-bone signaling axis in osteosarcopenia. [PDF]

EBioMedicine
Abdullah R, Chen J.
europepmc   +1 more source